Cardiac Resynchronization Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Cardiac Resynchronization Therapy Market is segmented By Product Type (CRT-Defibrillators, CRT-Pacemakers), By End User (Hospitals, Specialty Clinics,....
Cardiac Resynchronization Therapy Market Size
Market Size in USD Bn
CAGR6.4%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.4% |
| Market Concentration | High |
| Major Players | Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK, Microport Scientific Corporation and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Cardiac Resynchronization Therapy Market Analysis
The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.45 billion in 2024 and is expected to reach USD 10.83 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Advancements in cardiac devices along with the rising geriatric population suffering from chronic heart conditions are major factors driving the growth of this market.